Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?

Fasciitis, Plantar Clinical Trial

Official title:

Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01429883
• Other study ID #: ESWTRUZ01
• Status: Completed
• Phase: Phase 4
• First received: September 5, 2011
• Last updated: June 2, 2015
• Start date: July 2011
• Est. completion date: January 2015

Study information

• Verified date: May 2015
• Source: University of Zurich
• Contact: n/a
• Is FDA regulated: No
• Health authority: Switzerland: Ethikkommission
• Study type: Observational

Clinical Trial Summary

Patients with Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get the shock wave therapy in our clinic as planned. During our study the investigators want to ask for pain, pain reduction and function.

Description:

Patients with either Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get a shock wave therapy in our clinic of rheumatology as planned. During our study the investigators ask for pain, pain reduction and function (all questionnaires).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 36
• Est. completion date: January 2015
• Est. primary completion date: January 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

-Patients with:

• Fascititis plantaris,

• Achillodynie,

• Periarthropathia humerosacpularis calcarea or

• Epicondylopathia humeri /radii, who got the shock wave therapy.

Exclusion criteria:

• Anticoagulation,

• Sepsis

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Achillodynia
• Epikondylopathia Humeri /Radii
• Fasciitis, Plantar
• Periarthritis
• Periarthritis Calcarea

Locations

Country	Name	City	State
Switzerland	University Hospital	Zurich

Sponsors (1)

Lead Sponsor	Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland,